Biomedical, Clinical & Life Sciences

Request Ticket // Limit: 1 per department 

L. O'Neill - (Center on Aging)

Limiting Language
My organization is a government, a tribal entity, or a university: You may submit one application per department. You may submit another if, and only if, you are collaborating with another organization.  
o If you would like to submit a second application on behalf of a collaborative group of organizations, submit only one application per project. This means choosing just one organization to submit the collaborative application.  
o If several departments are applying for the same project, please treat it as a collaborative application. 
o A government or tribal agency, or university may apply for projects separate from those the individual departments apply for.   

Grant Description
All organizations requesting grants must provide services that directly benefit populations residing in Cochise County and eastern Santa Cruz Counties. 

The Legacy Foundation of Southeast Arizona is seeking applications for Innovative grants.  

Grant Cycle – June 2, 2025 through September 26, 2025. Awards will be announced by December 13, 2025.  Grants will be awarded January 2026.  

Every year the Legacy Foundation of Southeast Arizona funds Innovation Grants for projects up to $50,000 that are aligned with the Foundation Mission of Promoting Population Health and Community Wellness. 

Collaboration and forging partnerships with other community organizations are key determinants in funding decisions. 

The Legacy Foundation of Southeast Arizona will kick off the Innovative Grant Cycle with a workshop that will provide full information regarding the goals of the cycle. 
 

Apply to Internal Competition // Limit: 4* (see below) // Tickets Available: 3

Cancer Data Science // Limit: 1 // Tickets Available: 1

Cancer Control Science // Limit: 1 // Tickets Available: 0
S. Yeo (Public Health - Competitive Resubmission) 

Molecular Precision/Cancer Prevention // Limit: 1 // Tickets Available: 1 

Other Cancer Research // Limit: 1 // Tickets Available: 1

Number of Applications
Applicant organizations may submit more than one application, provided that each application is scientifically distinct, and each is from a different candidate.

Limit: 1 // Tickets Available: 0

Kevin Rhine (Pharmacology/Toxicology)

Limiting Language
The University of Arizona is invited to nominate one promising candidate for the award.  

Overview 
The Rita Allen Foundation Scholars Program provides grants to leading biomedical research institutions selected by the Rita Allen Foundation Scientific Advisory Committee and within parameters defined by the Rita Allen Foundation Board of Directors. The Scholars Program supports research scientists in the early stages of their careers. Fields of research are cancer, immunology and neuroscience. The Rita Allen Foundation reviews grant proposals by invitation only. Individuals chosen will be designated Rita Allen Foundation Scholars and the affiliated institution will receive financial support from the Rita Allen Foundation of up to $110,000 annually, for a period of up to five years. 

Eligibility
To be eligible for a Rita Allen Foundation Scholars Award candidates must: 

• Be nominated by a selected institution
• Have completed their training and provided persuasive evidence of distinguished achievement or extraordinary promise in research in one of the relevant fields
• Be in the early stages of their careers; most likely, this will mean a recent appointment at a faculty level

Rita Allen Foundation Scholars may not accept an award from the Beckman Young Investigator Program, Pew Scholars Program in the Biomedical Sciences, Searle Scholars Program, or Vallee Scholars Program that would take effect beginning in year one of the RAF award. Rita Allen Scholars may apply for awards from these organizations that would take effect beginning in year two of the RAF award. Other sources of funding also may influence selection. 

Request Ticket // Limit: 2 per department

Limiting Language
Applicants must be approved by their department to apply for the PBF Fellowship. Institutions may have no more than three Parker B. Francis Fellows in a single department at a given time, a department may submit nor more than two applications annually, and a mentor may sponsor only one application annually.

Executive Summary
The Parker B. Francis Fellowship provides research support to clinical and basic scientists embarking on careers in clinical, laboratory or translational science related to Pulmonary, Critical Care and Sleep Medicine at a U.S. or Canadian university or research institution. The ideal candidate is one with evidence of strong aptitude in research and who is in transition from post-doctoral trainee to independent investigator. It is essential that there be evidence of accomplishment and proficiency in research. Few applicants who are just beginning research training and have only one or two research publications are funded.

Request Ticket // Limit: 1 // Tickets Available: 1

Limiting Language
You may not submit more than one application. If you submit more than one application, we will only accept the last on-time submission.

Summary
The Health Resources and Services Administration (HRSA)’s HIV/AIDS Bureau (HAB) is accepting applications for the fiscal year (FY) 2025 Ryan White HIV/AIDS Program (RWHAP) Part F Community Based Dental Partnership Program (CBDPP), Learning Collaborative for HIV Oral Health and Primary Care Integration, cooperative agreement.

This cooperative agreement will:

• promote information sharing and exchange

• maintain and strengthen oral health and primary care integration

• improve dental education and training through interprofessional training and community-based education

• support community-based dental leaders in HIV oral health care

Request Ticket // Limit: 1 // Tickets Available: 1

Limiting Language
Number of Applications Only one application per institution (normally identified by having a unique DUNS number or NIH IPF number) is allowed. A single consolidated, application from several institutions within the same Metropolitan Statistical Area, as defined by the Office of Management and Budget (MSA, https://www.whitehouse.gov/omb/information-regulatory-affairs/statistic…) is strongly encouraged and preferred. A MSA consists of the county or counties (or equivalent entities) associated with at least one urbanized area of at least 50,000 population, plus adjacent counties having a high degree of social and economic integration with the core as measured through commuting ties (https://www.census.gov/programs-surveys/metro-micro/about/glossary.html). To assist applicants in determining the boundaries of MSAs, please utilize the delineation files resource at the U.S. Census website (https://www.census.gov/geographies/reference-files/time-series/demo/metro-micro/delineation-files.html) or contact the NIDDK program staff.

Purpose
The Division of Kidney, Urologic, and Hematologic Diseases (KUH) of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) aims to reshape and refocus its Institutional Training Award (T32) program. Compared to the traditional NIDDK/KUH NRSA T32 programs, the program supported by this Notice of Funding Opportunity (NOFO) will have fewer, larger Institutional Network Awards (U2C-TL1). These U2C-TL1 awards will be designed to cultivate a highly integrated cohort of people and resources to propel KUH training and research. The U2C cooperative component will coordinate and provide administrative support for the Institutional Network Award activities, while the TL1 training component will allow the institution to recruit and fund at least 5 highly competitive pre- and/or post-doctoral trainees across K-, U-, and H-mission focused research. With coordinated support from an Administrative Core, each U2C-TL1 Award is expected to:

• Enhance Career Preparation (U2C Professional Development Core). Promote interdisciplinary approaches to prepare trainees for the next step in their scientific careers by exposing them to innovative technologies and critical research resources. Develop tailored and structured educational experiences, including specific training in professional development, leadership, entrepreneurship, and mentorship.
• Increase Networking and Outreach (U2C Networking Core). Coordinate a vibrant and dynamic cohort of K, U, and H trainees, including those supported directly by the TL1 component of this award and those institutional trainees already supported by other NIH training mechanisms, such as Fellowships (Fs), Career Development Awards (Ks), Short-term Training Grants (T35s), and Education Program Grants (R25s). Support a robust mentoring environment, including active peer-to-peer and alumni networks.
• Recruit and Train Interdisciplinary Researchers (TL1 Training Core). Fund highly talented trainees from scientifically broad backgrounds via the TL1 component of this award.

Successful programs will provide an environment that will optimize the ability of trainees to conduct rigorous, ethical research to generate new knowledge, apply interdisciplinary approaches to research questions, and utilize principles of team-science to further their leadership and problem-solving skills. Programs should also support the development of a peer-to-peer network and provide ample career development resources for the community of K, U, and H trainees within the institution. Trainees who complete training under this program are expected to experience a strong, individually tailored, research foundation that permits them to communicate effectively through scientific presentations, compete for additional research support and be prepared to successfully navigate the next steps in a research or scientific career. Resources provided through the U2C activities are expected to accelerate the achievement of these milestones and enhance the establishment of a training community at the awardee institutions.

To foster a true community of trainees, applicant organizations may submit only one Institutional Network Award application. A single, consolidated application from several institutions within the same metropolitan area, that include multiple departments with a different research focus are strongly encouraged. Programs should include trainees across the entire KUH research mission. In other words, trainees may be engaged in benign kidney, urologic, or hematologic research within a single program. Institutional Network Awards applications that engage trainees across all three K-, U-, and H- disciplines are encouraged. While equal representation across these disciplines is not required, NIDDK encourages applicants to leverage available resources -- to the extent possible -- to maximize the training opportunities across K-, U- AND H- research. This may be accomplished by partnering with other departments within a given institution or by partnering with other institutions in the Metropolitan Statistical Area (if feasible). Multi-institutional applications are not required, but they are encouraged if partnership enhances the training environment and experience.

Over time, it is expected that each Institutional Network Award will actively participate in a nationwide program -- formed by the collection of individual KUH U2C-TL1 awards -- to train a cohort of researchers capable of achieving the scientific breakthroughs necessary to improve the care of people with kidney, urologic, and hematologic diseases
 

Limit: 1 // Tickets Available: 0

K. Huntoon (Neurosurgery)

Goal and Focus  

The goal of these grants is to overcome barriers to the clinical application of new treatment approaches for childhood cancer. A priority is to fund projects that have already shown great promise, but that have a specific funding need to move forward. 

The three main focus areas for this RFP are:  

• Cancer immunotherapy or targeted therapy  

• High-grade brain tumors or other difficult-to-treat pediatric cancers  

• Epigenetic modifying therapy or gene therapy  Applications of novel technologies (e.g. nanotechnology, omics, gene editing, bioinformatics, and AI) in these areas are welcome. 

Eligibility  

• Applications will only be accepted from Children’s Oncology Group member institutions in North  America (no citizenship requirements).  

• Open to PIs at all academic ranks with MD and/or PhD  

• Limit of one application per institution for either the Collaborative or the Individual grant with the  endorsement of the Chief(s) of the Division(s) of Pediatric Hematology-Oncology.  

 

The University of Arizona is not eligible due to an existing award.

Apply to internal competition // Limit: 2* // Tickets Available: 2

*The first submission may address any cancer type. A second submission is allowed but only for a translational or clinical stage project that primarily focuses on one of the following four cancer types: upper GI, glioblastoma, triple-negative breast cancer, or pancreatic cancer.

The University of Arizona Cancer Center (UACC) is coordinating this limited submission. For more information please contact: UACC-PreAward.

Purpose of the Award
The Mark Foundation Endeavor Awards support collaborative research projects that bring together investigators with diverse areas of expertise to tackle challenges in the prevention, diagnosis, and treatment of cancer. These grants are awarded to teams of three or more investigators to generate and integrate data from diverse lines of research and transform those insights into advances for cancer patients that could not be achieved by individual efforts. Basic, translational, and clinical projects are eligible. The project must seek to address an overarching, urgent scientific question. We welcome projects addressing substantial unmet needs in any type of cancer. We particularly encourage teams with innovative ideas for therapeutic strategies for upper GI, glioblastoma, triple-negative breast cancer, and pancreatic cancer to consider applying in this round.

The University of Arizona is not eligible for this funding opportunity

NIGMS will co-fund applications from higher education institutions that award undergraduate (B.S. or B.A.) and/or graduate degrees in biomedical sciences and have received no more than $6 million dollars per year (total costs) from NIH Research Project Grants (RPGs) in each of the preceding two fiscal years, calculated using NIH RePORTER, at the time of the application.  Applications to be considered must support research aligned with the NIGMS mission. Applications for research capacity building in Institutional Development Award (IDeA)-eligible states will be considered.